Ology Bioservices Wins $106M Army Contract for COVID-19 Vaccine Manufacturing Support (US DOD Newsroom)

Ology Bioservices Wins $106M Army Contract for COVID-19 Vaccine Manufacturing Support

UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), was awarded a $106,300,002 firm-fixed-price contract to reserve production capacity of approximately 186,840,000 doses to satisfy an urgent need for domestic aseptic fill and finish manufacturing of critical vaccines and therapeutics in support of the Operation Warp Speed response to the COVID-19 pandemic. 

Learn more about Ology Bioservices Wins $106M Army Contract for COVID-19 Vaccine Manufacturing Support.
X